NCT02849379View on ClinicalTrials.gov

Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

July 1, 2017

Study Completion Date

July 1, 2019

Conditions
Recurrent Tongue Cancer
Interventions
DEVICE

Cryosurgery

Percutaneous ablation under CT or ultrasound guidance

BIOLOGICAL

NK immunotherapy

Each treatment: 8\~10 billion cells in all, transfuion in 3 times, i.v.

Trial Locations (1)

510665

Fuda cancer institute of Fuda cancer hospital, Guangzhou

All Listed Sponsors
collaborator

Shenzhen Hank Bioengineering Institute

OTHER

lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02849379 - Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer | Biotech Hunter | Biotech Hunter